Objectives: To establish older women's (≥75 years) information preferences regarding 2 breast cancer treatment options: surgery plus adjuvant endocrine therapy versus primary endocrine therapy. To quantify women's preferences for the mode of information presentation and decision-making (DM) style. Methods: This was a UK multicentre survey of women, ≥75 years, who had been offered a choice between PET and surgery at diagnosis of breast cancer. A questionnaire was developed including 2 validated scales of decision regret and DM preferences. Results: Questionnaires were sent to 247 women, and 101 were returned (response rate 41%). The median age of participants was 82 (range 75 to 99), with 58 having had surgery and 37 having PET. Practical ...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Background: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 ...
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Objective Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor posit...
Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor pos...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in olde...
Purpose: Primary endocrine therapy (PET) is the treatment of primary, operable breast cancer with d...
Abstract: Background: Most studies on cancer patient preferences and information needs have not focu...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in old...
Introduction : Primary endocrine therapy (PET) is an alternative treatment to surgery for oestrogen ...
Introduction Primary endocrine therapy (PET) is used variably in the UK as an alternative to surg...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Background: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 ...
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Objectives: To establish older women's (≥75 years) information preferences regarding two breast canc...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Objective Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor posit...
Objective: Primary endocrine therapy (PET) is an alternative to surgery for oestrogen receptor pos...
Primary endocrine therapy (PET) as an alternative to surgery is widely used in the UK for the treatm...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in olde...
Purpose: Primary endocrine therapy (PET) is the treatment of primary, operable breast cancer with d...
Abstract: Background: Most studies on cancer patient preferences and information needs have not focu...
Objective Primary Endocrine Therapy (PET) is a good alternative to surgery for breast cancer in old...
Introduction : Primary endocrine therapy (PET) is an alternative treatment to surgery for oestrogen ...
Introduction Primary endocrine therapy (PET) is used variably in the UK as an alternative to surg...
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endoc...
Background: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 ...
BACKGROUND: Decisions about adjuvant chemotherapy in older women with early stage breast cancer (EBC...